Clinical trial
Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for…
NCT00160875 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00160875 |
|---|---|
| Title | Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer |
| Official title | A Phase II Study to Assess the Efficacy of Combined Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy (External Beam, Brachytherapy), Plus Surgery for Potentially Resectable Thoracic Esophageal Cancer |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | Irinotecan hydrochloride trihydrate, Cisplatin |
| Enrollment | 54 |
| Start date | Apr 1, 2009 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Sep 12, 2005 |
| Last update posted | May 4, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: